Isarna Therapeutics appoints Claus Schalper as CEO
Mr. Schalper joins Isarna with over 20 years of experience as an executive and serial entrepreneur in the life science and biotech industries.
Mr. Schalper joins Isarna from Pieris Pharmaceuticals, a company that he cofounded in 2001 and where he held the position of Chief Financial Officer among other roles.
He also cofounded XL protein GmbH.
Mr. Schalper began his career with Arthur Andersen and subsequently served as CEO for several companies in the technology industry. ■